Bone News and Research

RSS

Type 2 diabetes accelerates jawbone loss and causes tooth loss

Type 2 diabetes (T2D) is a chronic metabolic disorder whose global burden continues to rise. Beyond its systemic effects, T2D compromises skeletal health and markedly worsens loss of alveolar bone—the bone that anchors teeth—leading to tooth loosening, increased mobility, and eventual tooth loss.

11 Nov 2026

Childhood cancer survival reaches nearly 90%, yet disparities remain

Nearly nine in 10 young people with cancer were alive five years after diagnosis by 2017 – up from six in 10 in 1975, according to first comprehensive update of U.S. childhood cancer survival statistics in over a decade published in the Journal of the National Cancer Institute.

11 Nov 2026

Chronic stress promotes oral cancer through a brain–immune pathway

Chronic psychological stress is increasingly recognized as a risk factor for cancer, but how the brain communicates with the immune system to promote tumors has remained unclear.

11 Nov 2026

Gut microbial metabolites may reshape fat tissue through Wnt pathways

Fat tissue grows in two ways: existing fat cells swell, or progenitor cells spawn new fat cells. When new-cell formation falls behind long-term energy surplus, lipids pile up inside aging fat cells-bringing inflammation, insulin resistance, and fat deposits in the liver and muscle.

11 Nov 2026

‘Forever chemicals’ linked to slightly lower muscle mass in middle-aged women

A study of 551 middle-aged women found that higher blood concentrations of certain PFAS chemicals were associated with slightly lower muscle mass, particularly when researchers examined multiple chemicals together. However, these associations did not correspond to poorer muscle function, and the largely cross-sectional findings could not establish whether PFAS exposure contributes to muscle loss.

11 Nov 2026

Replacement PFAS chemical still harms developing zebrafish embryos

Publishing in the Journal of Hazardous Materials Advances, researchers from Kyushu University used zebrafish embryos to study the health effects of the PFAS called PFBS (Perfluorobutanesulfonic acid), a substitute PFAS thought to be safer than traditional compounds.

11 Nov 2026

Oral leukemia therapy offers effective at-home care for older adults

For years, older patients with acute myeloid leukemia-an aggressive cancer of the blood and bone marrow-have needed clinic injections five to seven days a month, plus a daily oral pill. For these older patients, that clinic schedule can be quite demanding.

11 Nov 2026

Can psychedelics help treat cancer beyond easing end-of-life fear?

A new peer-reviewed review in Psychedelics opens on a strange fact, gathered from existing laboratory studies rather than new experiments: a brain tumor can learn to eavesdrop.

11 Nov 2026

A child's sex may change how early sugar intake relates to body fat

A longitudinal study of 130 mother-child pairs found that added sugar intake during pregnancy was more strongly associated with body fat in girls, whereas exposure during infancy was more strongly associated with adiposity in boys at age two. The findings, based largely on a smaller group of 42 children with usable body-composition scans, are preliminary and do not establish a causal relationship.

9 Nov 2026

DNA methylation patterns predict treatment response in MDS patients

DNA methylation patterns present at diagnosis could help predict which patients with myelodysplastic syndromes (MDS) will respond to azacitidine.

9 Nov 2026

UCLA study identifies lipid imbalance as pulmonary fibrosis trigger

A new UCLA Health study in mice has identified a new potential trigger for pulmonary fibrosis: lipid dysregulation (a fat imbalance) within alveolar macrophages.

9 Nov 2026

$Refractory lichen planus-like lesions reveal underlying systemic T-cell lymphoma$

Refractory lichen planus-like lesions reveal underlying systemic T-cell lymphoma

A 61-year-old man had a 2-year history of painful mucosal lesions and pruritic violaceous plaques on the trunk and extremities.

6 Nov 2026

Towards a new approach to treating chronic blood disorders

A previously unrecognised weakness in the immune defenses against certain blood neoplasms could offer a promising target for future treatments.

6 Nov 2026

Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, will present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia (AML), in a poster session at the American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, Louisiana, December 12-15, 2026.

5 Nov 2026

New microscopy technique reveals how drugs affect living cells

How do cells respond to drugs? A new microscopy technique could provide more precise answers to this question in the future.

5 Nov 2026

ASH establishes new blood reference ranges for Duffy-null individuals

ASH has developed new reference ranges for children and adults with Duffy-null status, a common genetic trait associated with naturally lower circulating white blood cell counts that affects more than 66% of people with African or Mediterranean ancestry in the US.

5 Nov 2026